Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).
Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.
Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.
“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.
Read more on the Leiden University website.
A joint effort between Leiden University's Professor Ubbink's lab and ZoBio's Assay Development and Screening team has advanced fragment-based drug discovery targeting membrane...
Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung...
Leiden University Medical Center (LUMC) has achieved a national milestone by treating the first Dutch patient with an autoimmune disease using CAR-T cell therapy. This approach,...